Case File №
#VI-2026-0320
PepKits
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
33 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | X Unrated | 1 | 8.0 | 8.0 | 8.0 | 25 May 2026 |
| 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | X N/A | 1 | 4.0 | 0.2 | 0.2 | 17 Dec 2024 |
| 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | X N/A | 1 | 4.0 | 0.5 | 0.5 | 6 May 2025 |
| AA Water | X N/A | 1 | 4.0 | 0.6 | 0.6 | 20 Jun 2025 |
| AHK-CU | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Feb 2025 |
| Alprostadil | X N/A | 1 | 4.0 | 1.4 | 1.4 | 9 Jun 2025 |
| Anavar (Oxandrolone) Raw | X N/A | 1 | 4.0 | 1.6 | 1.6 | 27 Feb 2025 |
| BAM15 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| BPC-157 Capsule | X N/A | 1 | 4.0 | 0.0 | 0.0 | 27 Feb 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 24 Apr 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 6 May 2025 |
| Cartalax | X N/A | 1 | 4.0 | 1.0 | 1.0 | 11 Jun 2025 |
| Cerebrolysin | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Feb 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 4.0 | 0.6 | 0.6 | 17 Dec 2024 |
| Epithalon | X N/A | 1 | 4.0 | 0.6 | 0.6 | 8 Jul 2025 |
| EPO | X N/A | 1 | 4.0 | 1.6 | 1.6 | 2 Jul 2025 |
| GHRP-2 Acetate | X N/A | 1 | 4.0 | 0.0 | 0.0 | 16 Mar 2025 |
| Hyaluronic acid | X N/A | 1 | 4.0 | 0.2 | 0.2 | 7 May 2025 |
| L-Carnitine 500mg | X N/A | 1 | 4.0 | 1.6 | 1.6 | 3 Jun 2025 |
| LGD-4033 (Ligandrol) | X N/A | 1 | 4.0 | 0.3 | 0.3 | 17 Dec 2024 |
| Minoxidil Oral | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Jun 2025 |
| MOTS-C | X N/A | 1 | 4.0 | 0.4 | 0.4 | 24 Apr 2025 |
| NA Semax Amidate | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jul 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Feb 2025 |
| Nitroethane CAS 79-24-3 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Jul 2025 |
| Prednisone | X N/A | 1 | 4.0 | 0.0 | 0.0 | 24 Apr 2025 |
| Primobolan E | X N/A | 1 | 4.0 | 0.0 | 0.0 | 24 Apr 2025 |
| RIPEX 225 (TRA/Mast P/Test P) | X N/A | 1 | 4.0 | 2.2 | 2.2 | 6 May 2025 |
| S-23 Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Apr 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 4.0 | 2.3 | 2.3 | 11 Jun 2025 |
| Semaglutide Oral | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| Tesofensine | X N/A | 1 | 4.0 | 0.0 | 0.0 | 27 Feb 2025 |
| Test Propionate | X N/A | 1 | 4.0 | 0.0 | 0.0 | 20 Jun 2025 |
Exhibit II
Evidence Log
32 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | L-Carnitine 500mg | 4.0 C | 200mg/ml | 237.3mg/ml | +18.7% | 99.81% | ks9ese | Lab G | Public |
| 24 May 2026 | Nitroethane CAS 79-24-3 | 4.0 C | 5g | 5.8g | +15.1% | 97.40% | qu0wze | Lab D | Community |
| 24 May 2026 | 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | 5.3 B | 5g | 4.3g | -14.7% | 98.09% | pkq3z4 | Lab E | Public |
| 24 May 2026 | Cartalax | 4.0 C | 2mg | 2.1mg | +5.3% | 96.40% | ysix1z | Lab F | Public |
| 24 May 2026 | Cerebrolysin | 4.0 C | 2mg | 2.1mg | +5.4% | 97.83% | qimh25 | Lab G | Community |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 5.4 B | 15mg | 16.9mg | +12.3% | 99.79% | kd7an1 | Lab C | Public |
| 24 May 2026 | Hyaluronic acid | 4.0 C | 10mg | 9.2mg | -7.9% | 96.59% | 0m92ev | Lab A | Community |
| 24 May 2026 | Minoxidil Oral | 5.5 B | 50mg | 51.4mg | +2.9% | 95.76% | eynw8h | Lab G | Community |
| 24 May 2026 | AA Water | 5.2 B | 10mg | 10.9mg | +9.2% | 95.42% | 2oze4z | Lab B | Public |
| 21 May 2026 | MOTS-C | 4.0 C | 5mg | 4.4mg | -11.2% | 97.28% | 396m9q | Lab F | Community |
| 19 May 2026 | Anavar (Oxandrolone) Raw | 4.5 C | 5g | 5.7g | +13.9% | 95.75% | no3562 | Lab A | Public |
| 19 May 2026 | Tesofensine | 4.0 C | 25mg | 26.1mg | +4.3% | 97.35% | e3kn5u | Lab D | Public |
| 17 May 2026 | BAM15 | 4.4 C | 50mg | 43.3mg | -13.5% | 96.91% | sycucf | Lab C | Community |
| 17 May 2026 | EPO | 4.8 C | 15mg | 17.5mg | +16.5% | 96.49% | p3vdvr | Lab F | Public |
| 29 Jan 2026 | Primobolan E | 4.4 C | 300mg/ml | 366.7mg/ml | +22.2% | 98.60% | vouue9 | Lab C | Community |
| 26 Jan 2026 | Prednisone | 4.3 C | 100mg | 101.6mg | +1.6% | 95.63% | 1brbbm | Lab A | Public |
| 19 Jan 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 4.0 C | 50mg | 44.6mg | -10.8% | 96.09% | kquyv1 | Lab C | Community |
| 9 Jan 2026 | NA Semax Amidate | 4.5 C | 20mg | 22.4mg | +11.8% | 96.89% | nh6wcl | Lab B | Public |
| 9 Jan 2026 | Test Propionate | 4.0 C | 200mg/ml | 236.2mg/ml | +18.1% | 97.81% | gadw1n | Lab C | Community |
| 7 Jan 2026 | S-23 Raw | 4.0 C | 100g | 93.6g | -6.4% | 96.39% | hf5v6x | Lab G | Public |
| 6 Jan 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 5.4 B | 15mg | 16.0mg | +7.0% | 95.49% | jdossz | Lab F | Public |
| 29 Dec 2025 | 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | 4.0 C | 500g | 523.4g | +4.7% | 98.19% | x3rwd3 | Lab B | Public |
| 29 Dec 2025 | BPC-157 Capsule | 4.0 C | 20mg | 22.0mg | +9.8% | 96.04% | rc3cc6 | Lab G | Community |
| 29 Dec 2025 | GHRP-2 Acetate | 4.7 C | 10mg | 10.7mg | +6.9% | 98.81% | 5xk0ny | Lab G | Public |
| 23 Nov 2025 | Selank 10mg + Semax 10mg Blend | 4.0 C | 50mg | 54.6mg | +9.1% | 97.29% | e7ry65 | Lab A | Public |
| 5 Nov 2025 | RIPEX 225 (TRA/Mast P/Test P) | 4.0 C | 100mg/ml | 103.6mg/ml | +3.6% | 95.35% | q1vpfi | Lab F | Community |
| 17 Oct 2025 | AHK-CU | 4.0 C | 30mg | 26.1mg | -13.0% | 98.47% | nd5sue | Lab A | Public |
| 9 Oct 2025 | Alprostadil | 4.0 C | 20mg | 19.6mg | -2.1% | 96.91% | s0esiq | Lab D | Public |
| 9 Oct 2025 | Epithalon | 4.0 C | 2mg | 1.7mg | -12.8% | 95.88% | jhklb0 | Lab C | Public |
| 9 Oct 2025 | LGD-4033 (Ligandrol) | 6.2 A | 25mg | 22.2mg | -11.2% | 97.76% | 6ty16y | Lab G | Public |
| 9 Oct 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 4.2 C | 20mg | 23.6mg | +18.0% | 98.69% | zk1bxk | Lab G | Public |
| 9 Oct 2025 | Semaglutide Oral | 4.9 C | 100mg | 89.3mg | -10.7% | 95.08% | l8uvc8 | Lab D | Community |
— END OF EVIDENCE LOG —